Discount Agreements for Ranibizumab
The Techniker Krankenkasse aims to establish discount agreements for the active ingredient Ranibizumab to achieve cost-effectiveness. This concerns the biologics sector for the year 2026.
CONTRACTING AUTHORITY
Name
Techniker Krankenkasse
City
Hamburg
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
not-allowed
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
407 days remaining(LOT-0001)
Published